INSPIRE: A new opportunity for cancer pharmacoepidemiology research

Authors

  • Espen Enerly Department of Research, Cancer Registry of Norway, Norway
  • Lena Holmstrøm Department of Registration, Cancer Registry of Norway, Norway
  • Anna Skog Department of Registration, Cancer Registry of Norway, Norway
  • Kristin Oterholt Knudsen Department of Registration, Cancer Registry of Norway, Norway
  • Jan F. Nygård Department of Registry Informatics, Cancer Registry of Norway, Norway
  • Bjørn Møller Department of Registration, Cancer Registry of Norway, Norway
  • Giske Ursin Cancer Registry of Norway, Norway

DOI:

https://doi.org/10.5324/nje.v29i1-2.4043

Abstract

Until recently, there has been limited overview of the hospital administered cancer medications. The Cancer Registry of Norway has the approval to collect data on medical oncology treatment provided to each patient, but the reporting has so far been manual, time consuming and incomplete. Apart from conducting costly chart reviews, it has not been possible to carry out studies on hospital administered cancer medications. Efforts trying to improve manual reporting have not been sufficient and the most effective way of collecting data on cancer medications is through the hospital systems used for ordering/administering medical oncological treatment. The INSPIRE (INcreaSe PharmaceutIcal REporting) project was initiated to automatically and electronically collect data on cancer medication from the hospitals systems to the Cancer Registry. The project is a unique collaboration between 12 pharmaceutical companies, the Association of Pharmaceutical Companies in Norway, the Norwegian Cancer Society, Inven2, the Cancer Registry of Norway and the four Regional Health Trusts. In this article we describe the INSPIRE project, the data collection, and when and what kind of data that will be available. These new medication data at the Cancer Registry provide new opportunities for cancer pharmacoepidemiology research in Norway.

Downloads

Download data is not yet available.

Downloads

Published

2021-08-16

How to Cite

Enerly, E. ., Holmstrøm, L. ., Skog, A. ., Knudsen, K. O. ., Nygård, J. F. ., Møller, B., & Ursin, G. (2021). INSPIRE: A new opportunity for cancer pharmacoepidemiology research. Norsk Epidemiologi, 29(1-2). https://doi.org/10.5324/nje.v29i1-2.4043

Issue

Vol. 29 No. 1-2 (2021): Tema: Farmakoepidemiologi

Section

Articles

License

Copyright (c) 2021 Espen Enerly

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Norsk Epidemiologi licenses all content of the journal under a Creative Commons Attribution (CC-BY) licence. This means, among other things, that anyone is free to copy and distribute the content, as long as they give proper credit to the author(s) and the journal. For further information, see Creative Commons website for human readable or lawyer readable versions.

Authors who publish with this journal agree to the following terms:

1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).